Correspondence

Regarding “The Munich Vulnerability Study on Affective Disorders: Premorbid Polysomnographic Profile of Affected High-Risk Probands”

Consultant: Alzheimer’s Disease Antiinflammatory Prevention Trial (ADAPT), John C.S. Breitner, Principal Investigator, NIA U01-AG-15477 (member Data Safety Monitoring Board). Consultant: Lundbeck, Copenhagen (pending). Royalty: Multi-Health Systems, Toronto, Canada (Carroll Depression Scales). Travel support: Cyberonics Inc. (travel to Cyberonics workshop). Stock ownership over $10,000: none. Advisory boards: none. Patents: none. Speaker bureaus: none.